A joint guideline from two professional societies updates a 2020 recommendation statement.
Sponsoring Organizations: American Association for the Study of Liver Diseases (AASLD) and Infectious Diseases Society of America (IDSA)Background
With the development of highly effective direct-acting antivirals that are simple to administer and well-tolerated, the ability to eradicate chronic hepatitis C virus (HCV) globally is within reach. This updated version of a 2020 guideline (Hepatology 2020; 71:686) provides clinicians with a simple evidence-based approach.
Key Points
To achieve global eradication, HCV screening should be performed in all adults (age, ≥18) and all pregnant people during each pregnancy. Subsequent linkage to treatment is emphasized.
In most settings, the preferred treatment regimen is glecaprevir/pibrentasvir for 8 wee…
Reviewing Author
DisclosuresNothing to disclose
DisclosuresNothing to disclose